{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:48:33Z","timestamp":1791888513723,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd006843.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000}}],"reference-count":30,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006843.pub3","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T18:56:38Z","timestamp":1564426598000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Fetal fibronectin testing for reducing the risk of preterm birth"],"prefix":"10.1002","volume":"2019","author":[{"given":"Vincenzo","family":"Berghella","sequence":"first","affiliation":[{"name":"Thomas Jefferson University; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology; 833 Chestnut Street Level 1 Philadelphia Pennsylvania USA PA 19107"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Saccone","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Naples Federico II; Department of Neuroscience, Reproductive Science and Dentistry; 5 Pansini Naples Italy 80100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD006843.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00404-010-1712-x","article-title":"Pilot study into the efficacy of foetal fibronectin testing in minimising hospital admissions in women presenting with symptoms of preterm labour: a randomised controlled trial of obstetric and neonatal outcomes","volume":"284","author":"Dutta","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD006843.pub3-BIB0002|cit2","first-page":"S80","article-title":"Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs [abstract]","volume":"187","author":"Grobman","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajog.2003.11.034","article-title":"Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial","volume":"191","author":"Grobman","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0004|cit4","unstructured":"Burwick R York N Lee GT Ross MG Kjos SL Cervilenz assessment of cervical length is equivalent to fetal fibronectin in the prediction of preterm delivery American College of Obstetricians and Gynecologists' Annual Meeting; 2010 May 17-19; San Francisco, California, USA 2010"},{"issue":"1","key":"10.1002\/14651858.CD006843.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/14767058.2010.529201","article-title":"Cervilenz assessment of cervical length compared to fetal fibronectin in the prediction of preterm delivery in women with threatened preterm labor","volume":"24","author":"Burwick","year":"2011","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006843.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/14767058.2012.750291","article-title":"Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times?","volume":"26","author":"Lee","year":"2013","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006843.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S0002-9378(01)80232-5","article-title":"Effect of the fetal fibronectin assay on preterm labor management [abstract]","volume":"185","author":"Hansen","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajog.2003.08.041","article-title":"Prospective randomized trial of fetal fibronectin on preterm labor management in a tertiary care center","volume":"190","author":"Lowe","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006843.pub3-BIB0009|cit9","first-page":"97S","article-title":"The cost-effectiveness of fetal fibronectin testing in suspected preterm labor: a randomized trial","volume":"99","author":"Nguyen","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1067\/mob.2003.390","article-title":"Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms","volume":"188","author":"Plaut","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD006843.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0029-7844(03)00172-8","article-title":"Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women","volume":"101","author":"Andrews","year":"2003","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD006843.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajog.2004.02.019","article-title":"The randomized nitric oxide tocolysis trial (RNOTT) for the treatment of preterm labor","volume":"19","author":"Bisits","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD006843.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/sj.jp.7211359","article-title":"A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin","volume":"25","author":"Elliott","year":"2005","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0014|cit14","unstructured":"NCT03608995 Combined detection of interleukin-6 and insulin-like growth factor binding protein-1 total and native (premaquick) for the prediction of delivery in women with threatened preterm labor clinicaltrials.gov\/ct2\/show\/record\/NCT03608995"},{"issue":"2","key":"10.1002\/14651858.CD006843.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mob.2001.115998","article-title":"Metronidazole treatment of women with a positive fetal fibronectin test result","volume":"185","author":"Goldenberg","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006843.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0002-9378(01)80071-5","article-title":"Mid-trimester metronidazole and azithromycin did not prevent preterm birth in women at increased risk: a double-blind trial [abstract]","volume":"185","author":"Hauth","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0017|cit17","unstructured":"ISRCTN43735180 Randomised double blind placebo controlled trial of antimicrobial treatment in pregnant women at risk of preterm labour www.isrctn.com\/ISRCTN43735180"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006843.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1016\/S0029-7844(99)90112-6","article-title":"A randomized comparison of specimen collection methods for the fetal fibronectin immunoassay [abstract]","volume":"93","author":"Kalchbrenner","year":"1999","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0019|cit19","unstructured":"NCT00371046 The use of fetal fibronectin and transvaginal ultrasound cervical length in women with threatened preterm labor: a randomized trial clinicaltrials.gov\/ct2\/show\/NCT00371046"},{"issue":"4","key":"10.1002\/14651858.CD006843.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"426.el","DOI":"10.1016\/j.ajog.2007.07.017","article-title":"Does knowledge of cervical length and fetal fibronectin affect management of women with preterm labor? A randomized trial","volume":"197","author":"Ness","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD006843.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.ajog.2006.10.210","article-title":"Use of fetal fibronectin and transvaginal ultrasound cervical length to triage women with suspected preterm labor: a randomized trial","volume":"195","author":"Ness","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006843.pub3-BIB0022|cit22","first-page":"304","article-title":"The impact of fetal fibronectin assay on preterm labor management: a randomized controlled trial","volume":"23","author":"Os\u00f3rio","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD006843.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ajog.2008.09.148","article-title":"Minimal quantitative levels of fetal fibronectin (1-49 NG\/ML) at 24-27 weeks are associated with an increased risk of recurrent preterm delivery in asymptomatic patients with prior preterm birth","volume":"199","author":"Kurtzman","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD006843.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-0528.2005.00788.x","article-title":"A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study","volume":"113","author":"Shennan","year":"2006","journal-title":"British Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0025|cit25","unstructured":"NCT01431885 Randomized controlled trial of two methods of diagnosing preterm labor clinicaltrials.gov\/ct2\/show\/NCT01431885"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"30136","DOI":"10.1016\/j.ajog.2016.04.038","article-title":"Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Berghella","year":"2016","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0027|cit27","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD006843.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0002-9378(99)70612-5","article-title":"Cervico-vaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis","volume":"180","author":"Leitich","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006843.pub3-BIB0029|cit29","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD006843.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006843.pub2","article-title":"Fetal fibronectin testing for reducing the risk of preterm birth","author":"Berghella","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006843.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T15:02:17Z","timestamp":1667833337000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006843.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006843.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]}}}